全身化疗并大剂量654-2治疗胃肠道癌性疼痛的疗效观察

Clinical Observation of Chemotherapy and Anisodamine Hydrobromide for Digestive System Tumor Pain

目的评价全身化疗联合6542治疗胃肠道癌性疼痛的疗效。方法治疗组接受FLHP方案(CF+5Fu+HCPT+DDP)加大剂量6542;对照组给予胃复安。结果治疗组有效率为95.8%;对照组有效率20%。两组有显著性差异(P<0.01)。结论全身化疗加大剂量6542提高了治疗胃肠道癌性疼痛的疗效,改善了患者的生活质量。

Objective To evaluate the efficacy of anisodamine hydrobromide on digestive system tumor pain Methods Treatment group received FLHP regimen (5-Fluorouracil, Calcium Leucovorin, Hydroxycamptothecin, Cisplatin) plus anisodamine hydrobromide Control group regimen paspertin Results The effective rate of treatment group was 95 8%;The control group was 20% Significant difference was observed as compared with each other Conclusion FLHP regimen plus anisodamine hydrobromide enhanced the role of anti-digestive system tumor pain, so as to improve the quality of life of cancer pain